Clinical Trial Update: Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating the use of fibrinogen in high-risk cardiac surgery; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Complications During Procedures
• Cardiac Surgery Complications

Drugs mentioned

• Fibrinogen (fibrinogen)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Cardiac Complication During Procedure | Phase 3 | Status: COMPLETED | Results posted: 2020-05-22